JM Smucker Faces Lower Forward Estimates After JPMorgan Price Target Reduction JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India What It Means India and Vietnam Near BrahMos Missile Deal Implications for Defense Sector and Regional Security UK Spy Chief Warns of Moment of Consequence as Geopolitical Risks Mount for Western Allies IKEI 2026 MA Review First Four Months Signal Cautious Deal Activity AMD Plans 10 Billion Investment in Taiwans AI Chip Ecosystem to Propel NextGeneration Infrastructure VINP Q1 2026 Earnings Earnings Miss Pressures Shares Amid Disappointing Quarter IonQ Q1 2026 Earnings EPS Beat Highlights Progress in Quantum Commercialization HOG Q1 2026 Earnings EPS Beats Estimates by 1173 But Stock Edges Lower SPG Q1 2026 Earnings Slight EPS Miss Amid Stable Retail Fundamentals MYR Group Q1 2026 Earnings EPS Surges 44 Above Estimates Shares Climb Nearly 4 SBFM Q1 2026 Earnings PreRevenue Biotech Reports Net Loss of 025 Per Share Stock Falls 25 Altisource Portfolio Solutions Warrants ASPSW Decline 22 Approach Critical 038 Support Level Anavex Life Sciences AVXL Edges Higher Amid Biotech Sector Rotation HubSpot Holds Steady at 20083 Key Levels and Potential Scenarios for HUBS PC Connection Inc CNXN Gains 352 as Stock Moves Toward Resistance Sterling Infrastructure STRL Nears Resistance Amid Modest Gains UK Gilt Yields Retreat from MultiDecade Highs as Political Calm Returns and Rate Outlook Softens iQIYI Q1 2026 Earnings EPS Misses Estimates as Stock Declines 182 OXLCN Preferred Stock Holds Steady Near Par as Market Digests Interest Rate Outlook BW Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges HOUR Q4 2024 Earnings Loss Per Share of 004 Reported Amid Quiet Trading Best Buy Q1 2026 Earnings EPS Beats Estimates Stock Reacts Positively Thomson Reuters TRI Q1 2026 Earnings EPS Beats Estimates on Operational Strength OUST Q1 2026 Earnings EPS Beat Drives Positive Market Reaction GRC Q1 2026 Earnings Earnings Per Share Surpasses Estimates by 28 MeiraGTx Q1 2026 Earnings WiderthanExpected Loss Highlights Cash Burn Amid Clinical Progress